Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-02-24
1998-01-13
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, A61K 3156
Patent
active
057079838
ABSTRACT:
Alzheimer's disease and immune deficiency disorders may be effectively treated by administering a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis by administering a therapeutic amount of a .DELTA.5-Androstene-3.beta.-ol-17-one having a C.sub.7 substituent selected from the group consisting of oxo, hydroxy and groups convertible thereto by hydrolysis.
REFERENCES:
patent: 5206008 (1993-04-01), Loria
patent: 5461042 (1995-10-01), Loria
Criares Theodore J.
Humanetics Corporation
Sherrill Michael S.
LandOfFree
Treatment of alzheimer's disease and modulation of immune system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of alzheimer's disease and modulation of immune system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of alzheimer's disease and modulation of immune system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-326367